🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › New York › Greenburgh

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Greenburgh, NY keessatti

Qorannoo 18 Leukemia Myeloidii Hamaa f Greenburgh fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Bergen, Montvale · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 1
  • New York Medical College /ID# 275597, Valhalla · Miili 5 fagaatti
6 Months – 17 Years · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07306832

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Bergen, Montvale · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Bergen, Montvale · Miili 9 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Bergen, Montvale · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Bergen, Montvale · Miili 9 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

A Study of CRD3874-SI in People With Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07661095

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Bergen, Montvale · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • New York Medical College, Valhalla · Miili 5 fagaatti
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • New York Medical College, Valhalla · Miili 5 fagaatti
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · Miili 9 fagaatti
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 17-Ado-2026 · NCT07392242

A Study of Revumenib and Mezigdomide in People With Leukemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · Miili 9 fagaatti
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT07356154

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · Miili 9 fagaatti
Umuriin 1 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT06017258

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Bergen, Montvale · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT05756777

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · Miili 9 fagaatti
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT07011004

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Gur-2026 · NCT06773208

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Namoota walitti qabaa jiraSadarkaa 2
  • White Plains Hospital, White Plains · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Ama-2026 · NCT05184842

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Greenburgh keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.